tirzepatide fda obesity approval for Zepbound (tirzepatide) injection, the first and only treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly Launches Self-Pay Vials

These are among the largest and most rigorous trials ever conducted for these indications

These decisions must always be made by a licensed medical professional after a full evaluation

No additional active compounds are included in this single-ingredient peptide product

Oleate increase neutral lipid accumulation, cellular respiration and rescues palmitate-exposed GLP-1 secreting cells by reducing ceramide-induced ROS

Our providers take a holistic approach to reproductive health and metabolic wellness, recognizing that hormonal health, weight, and overall wellbeing are interconnected

Since Ozempic is marketed for a different purpose (diabetes vs